In particular, plasma levels of the circulating caspase-4 were five-fold increased in lung cancer patients (95% CI, 2.603–3.372 ng/ml) compared to healthy subjects (95% CI, 0.3994–0.6219 ng/ml) (Figure 1A). Here, CASP4 is linked to lung cancer.